9.32 USD
↘ 0.28 (2.92%)AT CLOSE (11:59 AM EDT)
Arvinas, Inc
ARVNNASDAQ • USD
9.57
↗ 0.24 (2.63%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
9.57
↗ 0.24 (2.63%)
Market: CLOSED
Shares of Arvinas, Inc (ARVN) are trading at $9.33. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a concerning Altman Z-Score in the distress zone and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest ARVN is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 26, 2026.
Open?$9.53
High?$9.55
Low?$9.28
Prev. Close?$9.60
Volume?532.6K
Avg. Volume?803.8K
VWAP?$9.39
Rel. Volume?0.66x
Bid / Ask
Bid?$9.37 × 100
Ask?$9.80 × 500
Spread?$0.43
Midpoint?$9.59
Valuation & Ratios
Market Cap?609.4M
Shares Out?64.5M
Float?52.0M
Float %?80.6%
P/E Ratio?65.53
P/B Ratio?1.08
EPS?$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Themes
Employees
246
Market Cap
627.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-09-27
Address
395 WINCHESTER AVE
NEW HAVEN, CT 06511
Phone: 203-535-1456
NEW HAVEN, CT 06511
Phone: 203-535-1456
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?21
Momentum?85
Short Sent.?50
Piotroski F-Score?6/9Mixed
Altman Z-Score?1.52Distress
Confidence?58%Low
Short InterestElevated
Short % of Float?7.79%Elevated
Short Interest?4.1M
Days to Cover?3.3
Free Float52.0M
Avg Daily Volume1.2M
Settlement Date2026-08-14
Financial Health
Current Ratio?7.91Strong
Quick Ratio?7.91Strong
Cash Ratio?1.14Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score87/100
P/E?65.5PRICEY▾
Peers100
S&P8
P/B?1.08CHEAP▾
Peers100
S&P97
P/S?1.92CHEAP▾
Peers100
S&P68
P/FCF?N/A▾
EV/EBITDA?-47.3CHEAP▾
S&P97
EV/Sales?1.63CHEAP▾
Peers100
S&P82
Returns & Efficiency
ROE?1.7%WEAK▾
Peers50
S&P17
ROA?1.4%WEAK▾
Peers50
S&P15
Cash Flow & Enterprise
FCF?$-208800000
Enterprise Value?$515.4M
Fundamentals ratios updated end of day